Biotech Values

[io_io]

re: ARDM

"This program had been left for dead by various message-board posters, especially on SI."

By coincidence, it's also the second (APPA being the first) of two bladerunner/rfj1862 picks that were reviewed by email last week/weekend, and it lost out to APPA.

Seems extremely cheap, OTOH it's about to hit it's 52-week low, despite this morning's news.

Apparently the ARDM royalty is 6% - not huge but this is diabetes after all.